Public Health Advocates Seek Lower Prices For Hepatitis C Treatments
Nature: Hepatitis C drugs not reaching poor
“…Three decades after wrestling to lower the cost of AIDS drugs (prices fell from about US$10,000 per patient per year in the 1990s to less than $100 in the mid-2000s), [public health researchers] are once again asking how expensive life-saving medicines can be made affordable for patients…” (Callaway, 4/15).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.